← Eichor
Condition: Mania Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mania

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolar Disorder
NA · 1 location(s) · Centre Hospitalier St Anne · NCT07194278Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
Phase 1 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT03522545Deep Brain Stimulation-Induced Mania in Parkinson's Disease
Phase N/A · 1 location(s) · Albino Maia · NCT05444907Adaptation and Validation of the Hypomanic Personality Scale (HPS-6) to Romanian
Phase 1/Phase 2 · 1 location(s) · Babes-Bolyai University · NCT07399626An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Ma
Phase 2 · 6 location(s) · Neurocrine Biosciences · NCT07288320A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2
Phase 3 · 85 location(s) · Bristol-Myers Squibb · NCT06951711A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Phase 3 · 73 location(s) · Bristol-Myers Squibb · NCT06951698A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · 174 location(s) · Bristol-Myers Squibb · NCT06929273A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · 104 location(s) · Bristol-Myers Squibb · NCT07140913LHC-CIDI-5 in Hong Kong
Phase N/A · 1 location(s) · The University of Hong Kong · NCT06804525Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · 22 location(s) · Rapport Therapeutics Inc. · NCT07046494Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa
NA · 1 location(s) · University of Washington · NCT05703711A Novel Blood Test as a Biomarker in Mental Health
Phase N/A · 1 location(s) · Fraser Health · NCT06856161
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.